Common Contracts
2 similar Termination Agreement contracts by AEON Biopharma, Inc.
Polar Multi-Strategy Master FundTermination Agreement • March 19th, 2024 • AEON Biopharma, Inc. • Pharmaceutical preparations
Re: Agreement (the “Agreement”) by and Among AEON Biopharma, Inc., a Delaware corporation (f/k/a Priveterra Acquisition Corp.), a Delaware corporation (“Counterparty”), AEON Biopharma Sub, Inc. (f/k/a AEON Biopharma, Inc.), a Delaware corporation (“Target”), and Polar Multi-Strategy Master Fund, a Cayman Islands exempted company (“Seller,” “we,” “us,” and “our”), to terminate the Forward Purchase Agreement dated as of June 29, 2023 (the “Forward Purchase Agreement”)
ACM ARRT J LLCTermination Agreement • March 19th, 2024 • AEON Biopharma, Inc. • Pharmaceutical preparations
aw@aeonbiopharma.com AEON Biopharma, Inc.5 Park Plaza, Suite 1750Irvine, California 92614Email: aw@aeonbiopharma.comAttention: Chief Legal Officer
